A biomarker could help identify patients with lung cancer who are most likely to benefit from treatment with AstraZeneca and Daiichi Sankyo's TROP2-directed drug datopotamab deruxtecan (Dato-DXd). The ...
En Yahoo Finanzas, obtienes cotizaciones gratuitas de acciones, noticias actualizadas, recursos de administración del portafolio, datos de mercados internacionales, interacción social y tasas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results